Detalhe da pesquisa
1.
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
J Neurooncol
; 167(2): 349-359, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427131
2.
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.
J Neurooncol
; 135(3): 545-552, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28849310
3.
Exceptional and Sustained Response to Belzutifan in Von Hippel-Lindau Disease-Associated Central Nervous System Hemangioblastoma.
Cureus
; 16(1): e52979, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406059
4.
Progressive Multifocal Leukoencephalopathy Presenting as Primary CNS Malignancy in an Immunocompetent Patient.
Cureus
; 15(9): e45815, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876409
5.
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Neuro Oncol
; 22(10): 1505-1515, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32166308
6.
Phase II trial of temozolomide in patients with progressive low-grade glioma.
J Clin Oncol
; 21(4): 646-51, 2003 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12586801
7.
Treatment of spinal cord impact injury in the rat with transforming growth factor-beta.
J Neurol Sci
; 200(1-2): 33-41, 2002 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12127673
8.
Unusual Presentation of Lung Adenocarcinoma With Paraneoplastic Stiff Person Syndrome: Role of EGFR Tyrosine Kinase Inhibitors.
J Thorac Oncol
; 14(8): e179-e180, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345344
9.
Glioblastoma: background, standard treatment paradigms, and supportive care considerations.
J Law Med Ethics
; 42(2): 171-82, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25040381
10.
Cerebral amyloidoma mimicking intracranial tumor: a case report.
J Med Case Rep
; 4: 308, 2010 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20854655
11.
Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.
Neuro Oncol
; 12(9): 917-27, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20525765